Showing results (2011-2020 of 2,547) with videos related to

Sort By:
Pageof 255
Plos Genetics|October 13, 2018
Host genetics and the rumen microbiome jointly associate with methane emissions in dairy cowsGareth Frank Difford, Damian Rafal Plichta, Peter Løvendahl, et al.
American Journal of Human Genetics|September 5, 2025
Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distributionNikolas A Baya, Ilknur Sur Erdem, Samvida S Venkatesh, et al.
Acta Oncologica (Stockholm, Sweden)|January 25, 2014
Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II studyKenneth F Hofland, Steinbjørn Hansen, Morten Sorensen, et al.
Obesity Surgery|February 9, 2023
Follow-Up, Safety, and Satisfaction with Tele-bariatric Follow-Up Implemented During the COVID-19 French Lockdown: a 2-Year Follow-Up StudyAhmed Daouadji-Ghazouani, Judith Aron-Wisnewsky, Adriana Torcivia, et al.
Acta Neuropathologica Communications|November 29, 2025
Genomic heterogeneity drives distinct infiltration patterns in glioblastomaDylan Scott Lykke Harwood, Sara Blaabjerg Artzi, Vilde Pedersen, et al.
Diabetes|September 30, 2020
Relative Adipose Tissue Failure in Alström Syndrome Drives Obesity-Induced Insulin ResistanceTarekegn Geberhiwot, Shanat Baig, Cathy Obringer, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2019
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosisJeffrey I Weitz, Annelise Segers, Gary Raskob, et al.
European Journal of Clinical Investigation|May 26, 2012
Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudyTroels Thim, Michael Maeng, Anne Kaltoft, et al.
Investigational New Drugs|April 7, 2019
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinomaC Even, U Lassen, J Merchan, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2022
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impactIda Christine Jacobsen, Iben Spanggaard, Martin Højgaard, et al.
Pageof 255